Cross-sectional Study of Chinese Liver Cancer Patients
The goal of this cross-sectional study is to investigate the prevalence and risk factors of anxiety and depression and their relationships with immune functions and quality of life among liver cancer patients in the COVID-19 pandemic era. The objectives of this study are:

1. To examine the prevalence of anxiety and depression among patients with liver cancer during the COVID-19 pandemic.
2. To identify risk factors associated with anxiety and depression among these patients.
3. To determine the association between anxiety, depression, immune function, and quality of life among liver cancer patients.

Participants will be asked to fill a digital questionnaire.
Liver Cancer
OTHER: No intervention
Anxiety score, Participants' anxiety status with HADS, Baseline|Depression score, Participants' depression status with HADS, Baseline
Quality of life score (The EORTC QLQ-C30), The European Organization for Research and Treatment of Cancer(EORTC) Quality of Life Questionnaire results. Scores range from 0 to 100. A higher score represents a higher ("better") level of functioning, or a higher ("worse") level of symptoms., Baseline|Quality of life score (The EORTC QLQ-HCC18), The Hepatocellular Carcinoma Module of The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire. Scores range from 0 to 100. A higher score represents a high level of symptomatology or problems., Baseline|Immune variables 1, White blood cell counts (WBC). Collected from daily medical records., Baseline|Immune variables 2, Total neutrophil count. Collected from daily medical records., Baseline|Immune variables 3, Total lymphocyte count. Collected from daily medical records., Baseline|Immune variables 4, Total monocyte count. Collected from daily medical records., Baseline|Immune variables 5, Neutrophilic granulocyte percentage. Collected from daily medical records., Baseline|Immune variables 6, Percentage of lymphocytes. Collected from daily medical records., Baseline|Immune variables 7, Monocyte percentage. Collected from daily medical records., Baseline|Immune variables 8, C-reactive protein (CRP). Collected from daily medical records., Baseline
The goal of this cross-sectional study is to investigate the prevalence and risk factors of anxiety and depression and their relationships with immune functions and quality of life among liver cancer patients in the COVID-19 pandemic era. The objectives of this study are:

1. To examine the prevalence of anxiety and depression among patients with liver cancer during the COVID-19 pandemic.
2. To identify risk factors associated with anxiety and depression among these patients.
3. To determine the association between anxiety, depression, immune function, and quality of life among liver cancer patients.

Participants will be asked to fill a digital questionnaire.